nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—ORM1—Erlotinib—pancreatic cancer	0.08	0.644	CbGbCtD
Amoxapine—HTR3A—enteric nervous system—pancreatic cancer	0.0457	0.325	CbGeAlD
Amoxapine—HTR7—enteric nervous system—pancreatic cancer	0.0296	0.21	CbGeAlD
Amoxapine—ORM1—bile—pancreatic cancer	0.0215	0.153	CbGeAlD
Amoxapine—CYP2D6—Tamoxifen—pancreatic cancer	0.0195	0.157	CbGbCtD
Amoxapine—HTR2A—enteric nervous system—pancreatic cancer	0.0184	0.131	CbGeAlD
Amoxapine—CYP2D6—Erlotinib—pancreatic cancer	0.0166	0.133	CbGbCtD
Amoxapine—CYP2D6—Doxorubicin—pancreatic cancer	0.00818	0.0658	CbGbCtD
Amoxapine—ORM1—gall bladder—pancreatic cancer	0.00596	0.0424	CbGeAlD
Amoxapine—HTR3A—islet of Langerhans—pancreatic cancer	0.00437	0.0311	CbGeAlD
Amoxapine—HTR3A—digestive system—pancreatic cancer	0.00262	0.0186	CbGeAlD
Amoxapine—ADRA2A—islet of Langerhans—pancreatic cancer	0.00207	0.0147	CbGeAlD
Amoxapine—SLC6A4—digestive system—pancreatic cancer	0.002	0.0142	CbGeAlD
Amoxapine—HTR2B—digestive system—pancreatic cancer	0.00198	0.0141	CbGeAlD
Amoxapine—HTR7—digestive system—pancreatic cancer	0.0017	0.0121	CbGeAlD
Amoxapine—ADRA2A—pancreas—pancreatic cancer	0.00146	0.0104	CbGeAlD
Amoxapine—HRH1—digestive system—pancreatic cancer	0.00127	0.00901	CbGeAlD
Amoxapine—HTR2A—digestive system—pancreatic cancer	0.00106	0.00752	CbGeAlD
Amoxapine—CYP2D6—digestive system—pancreatic cancer	0.000963	0.00685	CbGeAlD
Amoxapine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000784	0.0024	CcSEcCtD
Amoxapine—Increased appetite—Epirubicin—pancreatic cancer	0.000782	0.0024	CcSEcCtD
Amoxapine—Confusional state—Irinotecan—pancreatic cancer	0.000781	0.00239	CcSEcCtD
Amoxapine—Asthenia—Erlotinib—pancreatic cancer	0.00078	0.00239	CcSEcCtD
Amoxapine—Pruritus—Tamoxifen—pancreatic cancer	0.000777	0.00238	CcSEcCtD
Amoxapine—Oedema—Irinotecan—pancreatic cancer	0.000775	0.00237	CcSEcCtD
Amoxapine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000769	0.00236	CcSEcCtD
Amoxapine—Pruritus—Erlotinib—pancreatic cancer	0.000769	0.00236	CcSEcCtD
Amoxapine—Purpura—Epirubicin—pancreatic cancer	0.000763	0.00234	CcSEcCtD
Amoxapine—Shock—Irinotecan—pancreatic cancer	0.000762	0.00234	CcSEcCtD
Amoxapine—Vascular purpura—Doxorubicin—pancreatic cancer	0.00076	0.00233	CcSEcCtD
Amoxapine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000759	0.00233	CcSEcCtD
Amoxapine—Oedema—Gemcitabine—pancreatic cancer	0.000755	0.00231	CcSEcCtD
Amoxapine—Hepatitis—Docetaxel—pancreatic cancer	0.000754	0.00231	CcSEcCtD
Amoxapine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000751	0.0023	CcSEcCtD
Amoxapine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00075	0.0023	CcSEcCtD
Amoxapine—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.00075	0.0023	CcSEcCtD
Amoxapine—Confusional state—Fluorouracil—pancreatic cancer	0.000748	0.00229	CcSEcCtD
Amoxapine—Abdominal pain—Sunitinib—pancreatic cancer	0.000744	0.00228	CcSEcCtD
Amoxapine—Body temperature increased—Sunitinib—pancreatic cancer	0.000744	0.00228	CcSEcCtD
Amoxapine—Diarrhoea—Erlotinib—pancreatic cancer	0.000743	0.00228	CcSEcCtD
Amoxapine—Oedema—Fluorouracil—pancreatic cancer	0.000742	0.00227	CcSEcCtD
Amoxapine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000739	0.00227	CcSEcCtD
Amoxapine—Anorexia—Irinotecan—pancreatic cancer	0.000739	0.00226	CcSEcCtD
Amoxapine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000727	0.00223	CcSEcCtD
Amoxapine—Dizziness—Tamoxifen—pancreatic cancer	0.000726	0.00223	CcSEcCtD
Amoxapine—Tachycardia—Fluorouracil—pancreatic cancer	0.000724	0.00222	CcSEcCtD
Amoxapine—Hypotension—Irinotecan—pancreatic cancer	0.000724	0.00222	CcSEcCtD
Amoxapine—Increased appetite—Doxorubicin—pancreatic cancer	0.000724	0.00222	CcSEcCtD
Amoxapine—Anorexia—Gemcitabine—pancreatic cancer	0.000719	0.00221	CcSEcCtD
Amoxapine—Dizziness—Erlotinib—pancreatic cancer	0.000718	0.0022	CcSEcCtD
Amoxapine—Anorexia—Fluorouracil—pancreatic cancer	0.000707	0.00217	CcSEcCtD
Amoxapine—Purpura—Doxorubicin—pancreatic cancer	0.000706	0.00216	CcSEcCtD
Amoxapine—Hypotension—Gemcitabine—pancreatic cancer	0.000705	0.00216	CcSEcCtD
Amoxapine—Insomnia—Irinotecan—pancreatic cancer	0.000701	0.00215	CcSEcCtD
Amoxapine—Vomiting—Tamoxifen—pancreatic cancer	0.000698	0.00214	CcSEcCtD
Amoxapine—Paraesthesia—Irinotecan—pancreatic cancer	0.000696	0.00213	CcSEcCtD
Amoxapine—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000694	0.00213	CcSEcCtD
Amoxapine—Hypotension—Fluorouracil—pancreatic cancer	0.000693	0.00213	CcSEcCtD
Amoxapine—Rash—Tamoxifen—pancreatic cancer	0.000692	0.00212	CcSEcCtD
Amoxapine—Dermatitis—Tamoxifen—pancreatic cancer	0.000692	0.00212	CcSEcCtD
Amoxapine—Ataxia—Epirubicin—pancreatic cancer	0.000691	0.00212	CcSEcCtD
Amoxapine—Vomiting—Erlotinib—pancreatic cancer	0.000691	0.00212	CcSEcCtD
Amoxapine—Somnolence—Irinotecan—pancreatic cancer	0.000689	0.00211	CcSEcCtD
Amoxapine—Headache—Tamoxifen—pancreatic cancer	0.000688	0.00211	CcSEcCtD
Amoxapine—Rash—Erlotinib—pancreatic cancer	0.000685	0.0021	CcSEcCtD
Amoxapine—Dermatitis—Erlotinib—pancreatic cancer	0.000684	0.0021	CcSEcCtD
Amoxapine—Insomnia—Gemcitabine—pancreatic cancer	0.000683	0.00209	CcSEcCtD
Amoxapine—Dyspepsia—Irinotecan—pancreatic cancer	0.000682	0.00209	CcSEcCtD
Amoxapine—Headache—Erlotinib—pancreatic cancer	0.000681	0.00209	CcSEcCtD
Amoxapine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000678	0.00208	CcSEcCtD
Amoxapine—Asthenia—Sunitinib—pancreatic cancer	0.000675	0.00207	CcSEcCtD
Amoxapine—Decreased appetite—Irinotecan—pancreatic cancer	0.000674	0.00206	CcSEcCtD
Amoxapine—Insomnia—Fluorouracil—pancreatic cancer	0.000671	0.00206	CcSEcCtD
Amoxapine—Somnolence—Gemcitabine—pancreatic cancer	0.000671	0.00206	CcSEcCtD
Amoxapine—Fatigue—Irinotecan—pancreatic cancer	0.000668	0.00205	CcSEcCtD
Amoxapine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000666	0.00204	CcSEcCtD
Amoxapine—Alopecia—Docetaxel—pancreatic cancer	0.000666	0.00204	CcSEcCtD
Amoxapine—Pruritus—Sunitinib—pancreatic cancer	0.000665	0.00204	CcSEcCtD
Amoxapine—Constipation—Irinotecan—pancreatic cancer	0.000663	0.00203	CcSEcCtD
Amoxapine—Somnolence—Fluorouracil—pancreatic cancer	0.00066	0.00202	CcSEcCtD
Amoxapine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000656	0.00201	CcSEcCtD
Amoxapine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000653	0.002	CcSEcCtD
Amoxapine—Nausea—Tamoxifen—pancreatic cancer	0.000652	0.002	CcSEcCtD
Amoxapine—Fatigue—Gemcitabine—pancreatic cancer	0.000651	0.00199	CcSEcCtD
Amoxapine—Constipation—Gemcitabine—pancreatic cancer	0.000645	0.00198	CcSEcCtD
Amoxapine—Nausea—Erlotinib—pancreatic cancer	0.000645	0.00198	CcSEcCtD
Amoxapine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000645	0.00198	CcSEcCtD
Amoxapine—Diarrhoea—Sunitinib—pancreatic cancer	0.000644	0.00197	CcSEcCtD
Amoxapine—Dysgeusia—Docetaxel—pancreatic cancer	0.000643	0.00197	CcSEcCtD
Amoxapine—Ataxia—Doxorubicin—pancreatic cancer	0.000639	0.00196	CcSEcCtD
Amoxapine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000638	0.00196	CcSEcCtD
Amoxapine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000634	0.00194	CcSEcCtD
Amoxapine—Eosinophilia—Epirubicin—pancreatic cancer	0.000629	0.00193	CcSEcCtD
Amoxapine—Pancreatitis—Epirubicin—pancreatic cancer	0.000623	0.00191	CcSEcCtD
Amoxapine—Dizziness—Sunitinib—pancreatic cancer	0.000622	0.00191	CcSEcCtD
Amoxapine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000622	0.00191	CcSEcCtD
Amoxapine—Abdominal pain—Irinotecan—pancreatic cancer	0.000612	0.00188	CcSEcCtD
Amoxapine—Body temperature increased—Irinotecan—pancreatic cancer	0.000612	0.00188	CcSEcCtD
Amoxapine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000611	0.00187	CcSEcCtD
Amoxapine—Vomiting—Sunitinib—pancreatic cancer	0.000598	0.00183	CcSEcCtD
Amoxapine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000597	0.00183	CcSEcCtD
Amoxapine—Rash—Sunitinib—pancreatic cancer	0.000593	0.00182	CcSEcCtD
Amoxapine—Dermatitis—Sunitinib—pancreatic cancer	0.000593	0.00182	CcSEcCtD
Amoxapine—Urticaria—Fluorouracil—pancreatic cancer	0.000589	0.00181	CcSEcCtD
Amoxapine—Headache—Sunitinib—pancreatic cancer	0.000589	0.00181	CcSEcCtD
Amoxapine—Syncope—Docetaxel—pancreatic cancer	0.000589	0.0018	CcSEcCtD
Amoxapine—Leukopenia—Docetaxel—pancreatic cancer	0.000587	0.0018	CcSEcCtD
Amoxapine—Pollakiuria—Epirubicin—pancreatic cancer	0.000587	0.0018	CcSEcCtD
Amoxapine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000587	0.0018	CcSEcCtD
Amoxapine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000582	0.00178	CcSEcCtD
Amoxapine—Palpitations—Docetaxel—pancreatic cancer	0.00058	0.00178	CcSEcCtD
Amoxapine—Weight increased—Epirubicin—pancreatic cancer	0.000578	0.00177	CcSEcCtD
Amoxapine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000577	0.00177	CcSEcCtD
Amoxapine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000576	0.00177	CcSEcCtD
Amoxapine—Convulsion—Docetaxel—pancreatic cancer	0.000569	0.00174	CcSEcCtD
Amoxapine—Hypertension—Docetaxel—pancreatic cancer	0.000567	0.00174	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—pancreatic cancer	0.000566	0.00174	CcSEcCtD
Amoxapine—Nausea—Sunitinib—pancreatic cancer	0.000559	0.00171	CcSEcCtD
Amoxapine—Asthenia—Irinotecan—pancreatic cancer	0.000556	0.0017	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—pancreatic cancer	0.000552	0.00169	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—pancreatic cancer	0.000552	0.00169	CcSEcCtD
Amoxapine—Dry mouth—Docetaxel—pancreatic cancer	0.000546	0.00167	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000543	0.00166	CcSEcCtD
Amoxapine—Asthenia—Gemcitabine—pancreatic cancer	0.000541	0.00166	CcSEcCtD
Amoxapine—Confusional state—Docetaxel—pancreatic cancer	0.00054	0.00166	CcSEcCtD
Amoxapine—Oedema—Docetaxel—pancreatic cancer	0.000536	0.00164	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—pancreatic cancer	0.000535	0.00164	CcSEcCtD
Amoxapine—Pruritus—Gemcitabine—pancreatic cancer	0.000534	0.00164	CcSEcCtD
Amoxapine—Diarrhoea—Irinotecan—pancreatic cancer	0.00053	0.00162	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000529	0.00162	CcSEcCtD
Amoxapine—Shock—Docetaxel—pancreatic cancer	0.000527	0.00162	CcSEcCtD
Amoxapine—Pruritus—Fluorouracil—pancreatic cancer	0.000525	0.00161	CcSEcCtD
Amoxapine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000524	0.00161	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—pancreatic cancer	0.000524	0.00161	CcSEcCtD
Amoxapine—Tachycardia—Docetaxel—pancreatic cancer	0.000523	0.0016	CcSEcCtD
Amoxapine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000516	0.00158	CcSEcCtD
Amoxapine—Dizziness—Irinotecan—pancreatic cancer	0.000512	0.00157	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—pancreatic cancer	0.000511	0.00157	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—pancreatic cancer	0.000511	0.00157	CcSEcCtD
Amoxapine—Anorexia—Docetaxel—pancreatic cancer	0.000511	0.00156	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—pancreatic cancer	0.000508	0.00156	CcSEcCtD
Amoxapine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000508	0.00156	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000506	0.00155	CcSEcCtD
Amoxapine—Hypotension—Docetaxel—pancreatic cancer	0.0005	0.00153	CcSEcCtD
Amoxapine—Vomiting—Irinotecan—pancreatic cancer	0.000493	0.00151	CcSEcCtD
Amoxapine—Dizziness—Fluorouracil—pancreatic cancer	0.000491	0.0015	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000489	0.0015	CcSEcCtD
Amoxapine—Rash—Irinotecan—pancreatic cancer	0.000489	0.0015	CcSEcCtD
Amoxapine—Dermatitis—Irinotecan—pancreatic cancer	0.000488	0.0015	CcSEcCtD
Amoxapine—Headache—Irinotecan—pancreatic cancer	0.000485	0.00149	CcSEcCtD
Amoxapine—Insomnia—Docetaxel—pancreatic cancer	0.000484	0.00148	CcSEcCtD
Amoxapine—Paraesthesia—Docetaxel—pancreatic cancer	0.000481	0.00147	CcSEcCtD
Amoxapine—Vomiting—Gemcitabine—pancreatic cancer	0.00048	0.00147	CcSEcCtD
Amoxapine—Somnolence—Docetaxel—pancreatic cancer	0.000476	0.00146	CcSEcCtD
Amoxapine—Rash—Gemcitabine—pancreatic cancer	0.000476	0.00146	CcSEcCtD
Amoxapine—Dermatitis—Gemcitabine—pancreatic cancer	0.000475	0.00146	CcSEcCtD
Amoxapine—Tinnitus—Epirubicin—pancreatic cancer	0.000474	0.00145	CcSEcCtD
Amoxapine—Headache—Gemcitabine—pancreatic cancer	0.000473	0.00145	CcSEcCtD
Amoxapine—Vomiting—Fluorouracil—pancreatic cancer	0.000472	0.00145	CcSEcCtD
Amoxapine—Dyspepsia—Docetaxel—pancreatic cancer	0.000471	0.00145	CcSEcCtD
Amoxapine—Hepatitis—Doxorubicin—pancreatic cancer	0.00047	0.00144	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000468	0.00143	CcSEcCtD
Amoxapine—Rash—Fluorouracil—pancreatic cancer	0.000468	0.00143	CcSEcCtD
Amoxapine—Dermatitis—Fluorouracil—pancreatic cancer	0.000467	0.00143	CcSEcCtD
Amoxapine—Decreased appetite—Docetaxel—pancreatic cancer	0.000466	0.00143	CcSEcCtD
Amoxapine—Headache—Fluorouracil—pancreatic cancer	0.000465	0.00142	CcSEcCtD
Amoxapine—Fatigue—Docetaxel—pancreatic cancer	0.000462	0.00142	CcSEcCtD
Amoxapine—Nausea—Irinotecan—pancreatic cancer	0.00046	0.00141	CcSEcCtD
Amoxapine—Constipation—Docetaxel—pancreatic cancer	0.000458	0.0014	CcSEcCtD
Amoxapine—Alopecia—Epirubicin—pancreatic cancer	0.000449	0.00138	CcSEcCtD
Amoxapine—Nausea—Gemcitabine—pancreatic cancer	0.000448	0.00137	CcSEcCtD
Amoxapine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000441	0.00135	CcSEcCtD
Amoxapine—Nausea—Fluorouracil—pancreatic cancer	0.000441	0.00135	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—pancreatic cancer	0.000439	0.00134	CcSEcCtD
Amoxapine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000438	0.00134	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—pancreatic cancer	0.000436	0.00134	CcSEcCtD
Amoxapine—Tension—Epirubicin—pancreatic cancer	0.000434	0.00133	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—pancreatic cancer	0.000433	0.00133	CcSEcCtD
Amoxapine—Nervousness—Epirubicin—pancreatic cancer	0.00043	0.00132	CcSEcCtD
Amoxapine—Body temperature increased—Docetaxel—pancreatic cancer	0.000423	0.0013	CcSEcCtD
Amoxapine—Abdominal pain—Docetaxel—pancreatic cancer	0.000423	0.0013	CcSEcCtD
Amoxapine—Vision blurred—Epirubicin—pancreatic cancer	0.000417	0.00128	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—pancreatic cancer	0.000416	0.00127	CcSEcCtD
Amoxapine—Agitation—Epirubicin—pancreatic cancer	0.000407	0.00125	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—pancreatic cancer	0.000404	0.00124	CcSEcCtD
Amoxapine—Tension—Doxorubicin—pancreatic cancer	0.000402	0.00123	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000401	0.00123	CcSEcCtD
Amoxapine—Nervousness—Doxorubicin—pancreatic cancer	0.000398	0.00122	CcSEcCtD
Amoxapine—Syncope—Epirubicin—pancreatic cancer	0.000397	0.00122	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—pancreatic cancer	0.000396	0.00121	CcSEcCtD
Amoxapine—Palpitations—Epirubicin—pancreatic cancer	0.000391	0.0012	CcSEcCtD
Amoxapine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000389	0.00119	CcSEcCtD
Amoxapine—Vision blurred—Doxorubicin—pancreatic cancer	0.000386	0.00118	CcSEcCtD
Amoxapine—Asthenia—Docetaxel—pancreatic cancer	0.000384	0.00118	CcSEcCtD
Amoxapine—Convulsion—Epirubicin—pancreatic cancer	0.000384	0.00118	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—pancreatic cancer	0.000382	0.00117	CcSEcCtD
Amoxapine—Pruritus—Docetaxel—pancreatic cancer	0.000379	0.00116	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—pancreatic cancer	0.000376	0.00115	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—pancreatic cancer	0.000369	0.00113	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—pancreatic cancer	0.000367	0.00113	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—pancreatic cancer	0.000367	0.00112	CcSEcCtD
Amoxapine—Diarrhoea—Docetaxel—pancreatic cancer	0.000366	0.00112	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—pancreatic cancer	0.000364	0.00112	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—pancreatic cancer	0.000362	0.00111	CcSEcCtD
Amoxapine—Oedema—Epirubicin—pancreatic cancer	0.000361	0.00111	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00036	0.0011	CcSEcCtD
Amoxapine—Shock—Epirubicin—pancreatic cancer	0.000355	0.00109	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—pancreatic cancer	0.000355	0.00109	CcSEcCtD
Amoxapine—Dizziness—Docetaxel—pancreatic cancer	0.000354	0.00109	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000354	0.00108	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—pancreatic cancer	0.000354	0.00108	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—pancreatic cancer	0.000353	0.00108	CcSEcCtD
Amoxapine—Anorexia—Epirubicin—pancreatic cancer	0.000344	0.00106	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—pancreatic cancer	0.000341	0.00105	CcSEcCtD
Amoxapine—Vomiting—Docetaxel—pancreatic cancer	0.000341	0.00104	CcSEcCtD
Amoxapine—Rash—Docetaxel—pancreatic cancer	0.000338	0.00104	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—pancreatic cancer	0.000338	0.00103	CcSEcCtD
Amoxapine—Dermatitis—Docetaxel—pancreatic cancer	0.000337	0.00103	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—pancreatic cancer	0.000337	0.00103	CcSEcCtD
Amoxapine—Headache—Docetaxel—pancreatic cancer	0.000336	0.00103	CcSEcCtD
Amoxapine—Oedema—Doxorubicin—pancreatic cancer	0.000334	0.00102	CcSEcCtD
Amoxapine—Shock—Doxorubicin—pancreatic cancer	0.000329	0.00101	CcSEcCtD
Amoxapine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000327	0.001	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—pancreatic cancer	0.000327	0.001	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—pancreatic cancer	0.000326	0.001	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—pancreatic cancer	0.000324	0.000994	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—pancreatic cancer	0.000321	0.000984	CcSEcCtD
Amoxapine—Anorexia—Doxorubicin—pancreatic cancer	0.000319	0.000977	CcSEcCtD
Amoxapine—Nausea—Docetaxel—pancreatic cancer	0.000318	0.000975	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—pancreatic cancer	0.000318	0.000975	CcSEcCtD
Amoxapine—Decreased appetite—Epirubicin—pancreatic cancer	0.000314	0.000963	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—pancreatic cancer	0.000312	0.000957	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—pancreatic cancer	0.000311	0.000955	CcSEcCtD
Amoxapine—Constipation—Epirubicin—pancreatic cancer	0.000309	0.000947	CcSEcCtD
Amoxapine—Insomnia—Doxorubicin—pancreatic cancer	0.000302	0.000927	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—pancreatic cancer	0.0003	0.00092	CcSEcCtD
Amoxapine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000298	0.000913	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—pancreatic cancer	0.000297	0.000911	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000295	0.000905	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000294	0.000902	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000291	0.000891	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—pancreatic cancer	0.000288	0.000883	CcSEcCtD
Amoxapine—Urticaria—Epirubicin—pancreatic cancer	0.000287	0.00088	CcSEcCtD
Amoxapine—Constipation—Doxorubicin—pancreatic cancer	0.000286	0.000876	CcSEcCtD
Amoxapine—Abdominal pain—Epirubicin—pancreatic cancer	0.000286	0.000875	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—pancreatic cancer	0.000286	0.000875	CcSEcCtD
Amoxapine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000275	0.000844	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000273	0.000838	CcSEcCtD
Amoxapine—Urticaria—Doxorubicin—pancreatic cancer	0.000266	0.000814	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000264	0.00081	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000264	0.00081	CcSEcCtD
Amoxapine—Asthenia—Epirubicin—pancreatic cancer	0.000259	0.000794	CcSEcCtD
Amoxapine—Pruritus—Epirubicin—pancreatic cancer	0.000256	0.000783	CcSEcCtD
Amoxapine—Diarrhoea—Epirubicin—pancreatic cancer	0.000247	0.000758	CcSEcCtD
Amoxapine—Asthenia—Doxorubicin—pancreatic cancer	0.00024	0.000735	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—pancreatic cancer	0.000239	0.000732	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—pancreatic cancer	0.000236	0.000725	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—pancreatic cancer	0.00023	0.000704	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000229	0.000701	CcSEcCtD
Amoxapine—Rash—Epirubicin—pancreatic cancer	0.000228	0.000698	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—pancreatic cancer	0.000228	0.000698	CcSEcCtD
Amoxapine—Headache—Epirubicin—pancreatic cancer	0.000226	0.000694	CcSEcCtD
Amoxapine—Dizziness—Doxorubicin—pancreatic cancer	0.000221	0.000678	CcSEcCtD
Amoxapine—Nausea—Epirubicin—pancreatic cancer	0.000215	0.000658	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—pancreatic cancer	0.000213	0.000651	CcSEcCtD
Amoxapine—Rash—Doxorubicin—pancreatic cancer	0.000211	0.000646	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—pancreatic cancer	0.000211	0.000645	CcSEcCtD
Amoxapine—Headache—Doxorubicin—pancreatic cancer	0.000209	0.000642	CcSEcCtD
Amoxapine—Nausea—Doxorubicin—pancreatic cancer	0.000199	0.000609	CcSEcCtD
Amoxapine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.41e-05	3.46e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.4e-05	3.44e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SRC—pancreatic cancer	1.4e-05	3.43e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.4e-05	3.42e-05	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.4e-05	3.41e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MYC—pancreatic cancer	1.39e-05	3.41e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFB1—pancreatic cancer	1.39e-05	3.4e-05	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.39e-05	3.4e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	1.39e-05	3.39e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	1.38e-05	3.38e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SRC—pancreatic cancer	1.38e-05	3.38e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	1.38e-05	3.36e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.36e-05	3.34e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—pancreatic cancer	1.36e-05	3.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.36e-05	3.33e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.36e-05	3.32e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—pancreatic cancer	1.35e-05	3.3e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NRAS—pancreatic cancer	1.35e-05	3.3e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—KRAS—pancreatic cancer	1.35e-05	3.3e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	1.35e-05	3.29e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—KRAS—pancreatic cancer	1.35e-05	3.29e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	1.35e-05	3.29e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.34e-05	3.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.34e-05	3.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	1.34e-05	3.27e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.34e-05	3.27e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—pancreatic cancer	1.33e-05	3.26e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.33e-05	3.26e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.33e-05	3.26e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.33e-05	3.26e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MYC—pancreatic cancer	1.33e-05	3.26e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NRAS—pancreatic cancer	1.33e-05	3.25e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	1.33e-05	3.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.33e-05	3.25e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.33e-05	3.24e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	1.32e-05	3.23e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.31e-05	3.21e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	1.31e-05	3.2e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	1.31e-05	3.2e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	1.3e-05	3.18e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	1.3e-05	3.18e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	1.3e-05	3.18e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.3e-05	3.18e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	1.3e-05	3.17e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	1.29e-05	3.16e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.29e-05	3.16e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—KRAS—pancreatic cancer	1.29e-05	3.15e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.27e-05	3.11e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	1.27e-05	3.1e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	1.27e-05	3.1e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	1.26e-05	3.08e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	1.26e-05	3.08e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—pancreatic cancer	1.26e-05	3.07e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.25e-05	3.06e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	1.25e-05	3.05e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	1.25e-05	3.05e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.24e-05	3.04e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	1.24e-05	3.03e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—pancreatic cancer	1.24e-05	3.03e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PIK3CA—pancreatic cancer	1.24e-05	3.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	1.24e-05	3.03e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PIK3CA—pancreatic cancer	1.24e-05	3.02e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	1.24e-05	3.02e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.23e-05	3.02e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	1.23e-05	3.01e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	1.23e-05	3e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	1.23e-05	3e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.22e-05	2.99e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.22e-05	2.99e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.22e-05	2.98e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.21e-05	2.97e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	1.21e-05	2.97e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—pancreatic cancer	1.21e-05	2.96e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.21e-05	2.95e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	1.2e-05	2.95e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	1.2e-05	2.94e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.2e-05	2.94e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.2e-05	2.94e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.2e-05	2.93e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	1.2e-05	2.93e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—pancreatic cancer	1.2e-05	2.93e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—pancreatic cancer	1.2e-05	2.93e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	1.19e-05	2.92e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	1.19e-05	2.92e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	1.19e-05	2.91e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PIK3CA—pancreatic cancer	1.18e-05	2.9e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	1.18e-05	2.89e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.18e-05	2.89e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.18e-05	2.89e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	1.17e-05	2.87e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	1.17e-05	2.86e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.17e-05	2.86e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	1.17e-05	2.85e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—pancreatic cancer	1.16e-05	2.85e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	1.16e-05	2.84e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	1.16e-05	2.84e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	1.16e-05	2.84e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	1.16e-05	2.84e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.16e-05	2.84e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	1.16e-05	2.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	1.16e-05	2.83e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	1.16e-05	2.83e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	1.15e-05	2.82e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.15e-05	2.82e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	1.15e-05	2.81e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	1.15e-05	2.81e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	1.15e-05	2.8e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.15e-05	2.8e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—pancreatic cancer	1.15e-05	2.8e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	1.14e-05	2.8e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	1.14e-05	2.8e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	1.14e-05	2.79e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.14e-05	2.78e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.14e-05	2.78e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.13e-05	2.76e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	1.13e-05	2.76e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.13e-05	2.76e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.13e-05	2.76e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	1.13e-05	2.75e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	1.12e-05	2.75e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	1.12e-05	2.74e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	1.12e-05	2.74e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.12e-05	2.73e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	1.11e-05	2.72e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	1.11e-05	2.72e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.11e-05	2.7e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	2.69e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.1e-05	2.68e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HRAS—pancreatic cancer	1.1e-05	2.68e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	1.09e-05	2.68e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—pancreatic cancer	1.09e-05	2.67e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	1.09e-05	2.67e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.09e-05	2.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.09e-05	2.66e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.08e-05	2.64e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.08e-05	2.63e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	1.07e-05	2.63e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	2.62e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	1.07e-05	2.62e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	1.07e-05	2.61e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1.06e-05	2.59e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SRC—pancreatic cancer	1.06e-05	2.59e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.06e-05	2.58e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.06e-05	2.58e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	1.05e-05	2.57e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	1.05e-05	2.57e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.05e-05	2.56e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	1.05e-05	2.56e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	1.04e-05	2.55e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SRC—pancreatic cancer	1.04e-05	2.54e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	1.04e-05	2.53e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—pancreatic cancer	1.03e-05	2.52e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	1.03e-05	2.52e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	1.03e-05	2.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	1.02e-05	2.5e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	1.02e-05	2.49e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	2.49e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	1.02e-05	2.49e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—pancreatic cancer	1.02e-05	2.49e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	1.01e-05	2.48e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	1.01e-05	2.47e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	1.01e-05	2.47e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	1.01e-05	2.47e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.01e-05	2.47e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	1e-05	2.45e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	1e-05	2.45e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	1e-05	2.45e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	9.99e-06	2.44e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	9.98e-06	2.44e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	9.98e-06	2.44e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	9.96e-06	2.44e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	9.96e-06	2.44e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	9.93e-06	2.43e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	9.92e-06	2.43e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	9.86e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	9.83e-06	2.4e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	9.83e-06	2.4e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	9.8e-06	2.4e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	9.73e-06	2.38e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	9.67e-06	2.37e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—pancreatic cancer	9.48e-06	2.32e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	9.47e-06	2.32e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	9.46e-06	2.31e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	9.33e-06	2.28e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—pancreatic cancer	9.31e-06	2.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	9.3e-06	2.28e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	9.28e-06	2.27e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	9.28e-06	2.27e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	9.27e-06	2.27e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	9.25e-06	2.26e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	9.23e-06	2.26e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	9.22e-06	2.26e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	9.21e-06	2.25e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	9.16e-06	2.24e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	9.13e-06	2.23e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	9.13e-06	2.23e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	9.12e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	9.12e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	9.12e-06	2.23e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	9.11e-06	2.23e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	9.11e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	9.1e-06	2.23e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	9.07e-06	2.22e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	8.93e-06	2.18e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	8.87e-06	2.17e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	8.82e-06	2.16e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	8.76e-06	2.14e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	8.71e-06	2.13e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	8.62e-06	2.11e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	8.61e-06	2.11e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	8.6e-06	2.1e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	8.59e-06	2.1e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	8.57e-06	2.1e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	8.49e-06	2.08e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	8.48e-06	2.07e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	8.46e-06	2.07e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	8.44e-06	2.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	8.44e-06	2.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	8.3e-06	2.03e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	8.05e-06	1.97e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTEN—pancreatic cancer	7.96e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	7.92e-06	1.94e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	7.9e-06	1.93e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	7.88e-06	1.93e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	7.84e-06	1.92e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—pancreatic cancer	7.78e-06	1.9e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	7.75e-06	1.9e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	7.66e-06	1.87e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—pancreatic cancer	7.64e-06	1.87e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	7.62e-06	1.86e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	7.5e-06	1.83e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	7.49e-06	1.83e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	7.45e-06	1.82e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	7.44e-06	1.82e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	7.33e-06	1.79e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	7.31e-06	1.79e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	7.29e-06	1.78e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	7.2e-06	1.76e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	7.17e-06	1.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—pancreatic cancer	7.04e-06	1.72e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	6.97e-06	1.7e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	6.66e-06	1.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	6.57e-06	1.61e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	6.47e-06	1.58e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	6.45e-06	1.58e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	6.43e-06	1.57e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	6.33e-06	1.55e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	5.88e-06	1.44e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	5.61e-06	1.37e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—pancreatic cancer	4.59e-06	1.12e-05	CbGpPWpGaD
